Showing results (361-370 of 375) with videos related to
Sort By:
Pageof 38
Acta Oncologica (Stockholm, Sweden)|October 2, 2024
Intensity-modulated proton radiotherapy spares musculoskeletal structures in regional nodal irradiation for breast cancer: a dosimetric comparisonJessica F Burlile, Satomi Shiraishi, Heather J Gunn, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 17, 2017
Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE studyS Valmary-Degano, P Colpart, L Villeneuve, et al.Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 13, 2023
Clinical aspects of spatially fractionated radiation therapy treatmentsMichael P Grams, Christopher L Deufel, James A Kavanaugh, et al.Journal of Medicinal Chemistry|May 5, 2011
Novel 4,4-disubstituted piperidine-based C-C chemokine receptor-5 inhibitors with high potency against human immunodeficiency virus-1 and an improved human ether-a-go-go related gene (hERG) profileWieslaw M Kazmierski, Don L Anderson, Christopher Aquino, et al.Transplantation Proceedings|May 19, 2019
Antibody-Mediated Rejection in a Multiple Lung Transplant Patient: A Case ReportP Radeczky, Á K Ghimessy, A Farkas, et al.Transplantation Proceedings|May 19, 2019
Lung Transplantation in Hungary From Cardiac Surgeons' PerspectiveL Fazekas, Á Ghimessy, B Gieszer, et al.British Journal of Cancer|January 31, 2015
Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter studyB Ghanim, T Klikovits, M A Hoda, et al.Journal of Medicinal Chemistry|November 28, 2006
Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1Francis X Tavares, Kamal A Al-Barazanji, Eric C Bigham, et al.Journal of Medicinal Chemistry|November 28, 2006
6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonistFrancis X Tavares, Kamal A Al-Barazanji, Michael J Bishop, et al.Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.Pageof 38